TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmetheus AB
Closing information (x1000 EUR)
Closing information | 2022/11 | 2021/11 | 2020/11 |
Turnover | 13,711 | 10,218 | 8,959 |
Financial expenses | 9 | 10 | 17 |
Earnings before taxes | 3,523 | 2,144 | 1,766 |
EBITDA | 3,573 | 2,196 | 1,817 |
Total assets | 6,724 | 4,105 | 3,160 |
Current assets | 6,602 | 3,996 | 3,088 |
Current liabilities | 2,719 | 1,788 | 1,489 |
Equity capital | 3,608 | 2,092 | 1,556 |
- share capital | 6 | 6 | 6 |
Employees (average) | 61 | 55 | 42 |
Financial ratios
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Solvency | 53.7% | 51.0% | 49.2% |
Turnover per employee | 225 | 186 | 213 |
Profit as a percentage of turnover | 25.7% | 21.0% | 19.7% |
Return on assets (ROA) | 52.5% | 52.5% | 56.4% |
Current ratio | 242.8% | 223.5% | 207.4% |
Return on equity (ROE) | 97.6% | 102.5% | 113.5% |
Change turnover | 4,138 | 1,328 | 1,988 |
Change turnover % | 43% | 15% | 29% |
Chg. No. of employees | 6 | 13 | 9 |
Chg. No. of employees % | 11% | 31% | 27% |
Total value of public sale
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.